Showing results (341-350 of 3,787) with videos related to

Sort By:
Pageof 379
Oncoimmunology|November 19, 2013
Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cellsMatilde Todaro, Serena Meraviglia, Nadia Caccamo, et al.
Oncoimmunology|November 19, 2013
The role of interleukin-10 in the progression of human papillomavirus-associated lung carcinomaWen-Wei Sung, Huei Lee
Oncoimmunology|November 20, 2019
PD-L1 regulation by SDH5 via β-catenin/ZEB1 signalingZhan Tuo, Yan Zong, Jie Li, et al.
Oncoimmunology|November 20, 2019
Complete response in patients with locally advanced rectal cancer after neoadjuvant treatment with nivolumabJianwei Zhang, Jian Cai, Yanhong Deng, et al.
Oncoimmunology|November 20, 2019
Antibiotic use and the efficacy of immune checkpoint inhibitors in cancer patients: a pooled analysis of 2740 cancer patientsXuan-Zhang Huang, Peng Gao, Yong-Xi Song, et al.
Oncoimmunology|November 20, 2019
Tumor-infiltrating lymphocytes from human prostate tumors reveal anti-tumor reactivity and potential for adoptive cell therapySharon Yunger, Assaf Bar El, Li-At Zeltzer, et al.
Oncoimmunology|November 20, 2019
Targeting the TIGIT-PVR immune checkpoint axis as novel therapeutic option in breast cancerHauke Stamm, Leticia Oliveira-Ferrer, Eva-Maria Grossjohann, et al.
Oncoimmunology|November 20, 2019
Patients with melanoma of unknown primary show better outcome under immune checkpoint inhibitor therapy than patients with known primary: preliminary resultsThilo Gambichler, Maria Chatzipantazi, Ulrike Schröter, et al.
Oncoimmunology|March 3, 2020
PT-112 induces immunogenic cell death and synergizes with immune checkpoint blockers in mouse tumor modelsTakahiro Yamazaki, Aitziber Buqué, Tyler D Ames, et al.
Oncoimmunology|March 3, 2020
Helper T cell-dominant tertiary lymphoid structures are associated with disease relapse of advanced colorectal cancerKyoko Yamaguchi, Mamoru Ito, Hirofumi Ohmura, et al.
Pageof 379